Don Hayden is a Senior Advisor to Prospect Venture Partners.
Mr. Hayden brings to Prospect the experiences and perspective resulting from a
highly-successful 25 year career with Bristol-Myers Squibb Company as well as the
insights gained from key roles at a number of smaller, more entrepreneurial pharmaceutical
and biotech companies over the past 5 years. At Bristol-Myers Squibb, Mr. Hayden served
as President of Global Pharmaceuticals; Executive Vice President and President, Americas,
overseeing two major pharmaceutical units and two healthcare businesses; Executive Vice
President of the Health Care Group; President of Oncology and Immunology; and Senior Vice
President for Worldwide Franchise Management and Business Development. Since leaving
Bristol-Myers Squibb in early 2006, Mr. Hayden has served as Chairman of Gloucester
Pharmaceuticals, Vitae Pharmaceuticals, Insmed, and Azelon Pharmaceuticals, as Lead
Director of Amicus Therapeutics, and as a Director of Otsuka Pharmaceuticals and Nora
Therapeutics. Mr. Hayden received his undergraduate degree from Harvard University
and has an M.B.A. from Indiana University.